Calliditas Therapeutics (CALT)
(Delayed Data from NSDQ)
$40.03 USD
+0.04 (0.10%)
Updated Sep 18, 2024 03:58 PM ET
After-Market: $40.33 +0.30 (0.75%) 7:58 PM ET
4-Sell of 5 4
D Value A Growth D Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/11/2024
Time: BMO |
9/2024 | $-0.10 | 0.00% |
Earnings Summary
For their last quarter, Calliditas Therapeutics (CALT) reported earnings of -$0.16 per share, missing the Zacks Consensus Estimate of -$0.13 per share. This reflects a negative earnings surprise of 23.08%. Look out for CALT's next earnings release on November 11, 2024. For the next earning release, we expect the company to report earnings of -$0.10 per share, reflecting a year-over-year increase of 82.76%.
Earnings History
Price & Consensus
Zacks News for CALT
Xencor (XNCR) Moves 14.3% Higher: Will This Strength Last?
CALT: What are Zacks experts saying now?
Zacks Private Portfolio Services